What Does Omnicell, Inc.'s (NASDAQ:OMCL) Share Price Indicate?
Omnicell, Inc. (NASDAQ:OMCL), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$32.65
Omnicell (OMCL) Banks on Product Launches, Global Growth
Omnicell: Steady Service Rollout Suggests Moderate Growth Ahead, Justifying Hold Rating
Is Now The Time To Look At Buying Omnicell, Inc. (NASDAQ:OMCL)?
Is Omnicell (NASDAQ:OMCL) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Here's Why Omnicell (OMCL) Should Be in Your Portfolio Now
Wells Fargo Maintains Omnicell(OMCL.US) With Hold Rating, Maintains Target Price $26
Wells Fargo analyst Stan Berenshteyn maintains $Omnicell(OMCL.US)$ with a hold rating, and maintains the target price at $26.According to TipRanks data, the analyst has a success rate of 55.8% and a t
Omnicell (OMCL) Gains From New Offerings Amid Cost Woes
Estimating The Intrinsic Value Of Omnicell, Inc. (NASDAQ:OMCL)
Investors Aren't Buying Omnicell, Inc.'s (NASDAQ:OMCL) Revenues
With a price-to-sales (or "P/S") ratio of 1.3x Omnicell, Inc. (NASDAQ:OMCL) may be sending bullish signals at the moment, given that almost half of all the Medical Equipment companies in the United St
Analysts' Opinions Are Mixed on These Healthcare Stocks: Omnicell (OMCL), Tandem Diabetes Care (TNDM) and Amgen (AMGN)
Buy Rating on Omnicell Affirmed: Innovation and Growth Outlook Fuel Optimism for FY24 and Beyond
Piper Sandler Keeps Their Buy Rating on Omnicell (OMCL)
Omnicell | 10-Q: Quarterly report
Omnicell Supports Global Charity Mercy Ships With Pharmacy Technology Donation
Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leader in transforming the pharmacy care delivery model, today announced continued support for the global charity Mercy Ships with the donation of solutions
Analysts Conflicted on These Healthcare Names: PROCEPT BioRobotics (PRCT), Springworks Therapeutics (SWTX) and Omnicell (OMCL)
Omnicell to Present at the BofA Securities 2024 Health Care Conference
Omnicell, Inc. (NASDAQ:OMCL), a leader in transforming the pharmacy care delivery model, will present at the BofA Securities 2024 Health Care Conference in Las Vegs, NV, on Wednesday, May 15, 2024 at 3:40 p.m.
Express News | Benchmark Reiterates Buy on Omnicell, Maintains $38 Price Target
Omnicell Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 25.62% Benchmark → $38 Reiterates Buy → Buy 04/30/2024 25.62% Benchmark → $38 Reiterates Buy →
Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN), Amgen (AMGN) and Omnicell (OMCL)